Remimazolam for Bronchoscopy in High-Risk Patients — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Remimazolam for Bronchoscopy in High-Risk Patients — Stella

Recruiting

Back to Pulmonary Infection trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(2 sites)

China

The First Affliated Hospital, Zhejiang University School Of Medicine, Hangzhou, Zhejiang

Shaoxing City First People's Hospital, Shaoxing, Zhejiang

Key details

Phase

Post-approval study

Sponsor

First Affiliated Hospital of Zhejiang University

Collaborators

Shaoxing People's Hospital, Affiliated Hospital of Jiaxing University

Enrollment target

~360 participants

Started

February 2026

Primary completion

December 2026

Age range

18 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov